AlphaQuest’s Sagimet Biosciences SGMT Stock Holding History

AlphaQuest’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,174	Closed	-$36.5K	–	1734
2025 Q4	$36.5K	Sell	6,174 -111,085	-95%	-$798K	﹤0.01%	2014
2025 Q3	$804K	Buy	+117,259	New	+$951K	0.05%	527

Other funds holding SGMT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AlphaQuest's SGMT Position: Q1 2026 in Review

AlphaQuest sold out of Sagimet Biosciences (SGMT) in Q1 2026, closing a stake of 6,174 shares — an estimated $36.5K sold.

AlphaQuest first reported a position in SGMT in Q3 2025 and held it in 2 quarters. The position peaked at $804K in Q3 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

AlphaQuest reported no remaining Sagimet Biosciences position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 6,174 Sagimet Biosciences shares in Q1 2026, an estimated $36.5K.
AlphaQuest first reported a position in Sagimet Biosciences in Q3 2025 and held it in 2 quarters.
AlphaQuest's Sagimet Biosciences position peaked at $804K in Q3 2025.
88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.